More
    Guided Solutions - Connecting Talent With Innovation/div>

    Oath Surgical raises $24 million for surgical AI ecosystem

    Oath Surgical raised $24 million in its Series A financing round to support its AI-based surgical centers. FPV Ventures led the financing round. The company...

    Panda Surgical raises $1.3M for handheld neurosurgical robot

    Panda Surgical recently announced the closing of a strategic investment worth £1 million ($1.34 million) to support its handheld robotic system. Oxford Investment Consultants led...

    Spineart raises CHF 25M to boost global expansion and spine surgery innovation

    Swiss MedTech company Spineart has secured a CHF 25 million investment to accelerate its international growth and bring new technologies to the spine surgery...

    DermaSensor raises $16M Series B to support skin cancer detection device

    DermaSensor raised $16 million in a Series B funding round to fuel its commercial expansion efforts. The Miami-based company said its latest funding brings its...

    QT Imaging announces $18M private placement financing

    QT Imaging Holdings entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in...

    AiM Medical Robotics raises $8.1m for MRI-compatible surgical robotics

    AiM Medical Robotics closed a Series A financing round worth proceeds of $8.1 million. IQ Capital and 1540 Ventures led the round, which also had...

    RDS raises €14m to bolster market penetration of patient monitoring wearable

    French medical device company RDS has raised €14m ($16.4m) to accelerate the European market roll-out of MultiSense, a remote patient monitoring (RPM) wearable. The company’s...

    Navigation Sciences receives $400,000 STTR grant for its NaviSci System

    Navigation Sciences announced it has received a $400,000, Phase 1, Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI) to support...

    Axon Therapies raises $32m funding to transform heart failure treatment

    Axon Therapies, a clinical-stage medical device company pioneering a new approach to treating heart failure, today announced the close of an oversubscribed $32 million Series A...

    Latest articles